Clinical Trials
25 trialsNCT03499808 2025-09-09
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
SWOG Cancer Research Network
Phase 2 Completed
NCT06960122 2025-05-07
FMT-TP
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Not yet recruiting
NCT06576986 2024-08-29
Effect of Synbiotic Supplementation on the Prevention of Mucositis in Cancer Patients Undergoing Chemotherapy
Federal University of Minas Gerais
Phase NA Recruiting
NCT06019312 2023-08-31
L. Plantarum 299v and Gut Microbiome, Diarrhoea, and Clostridioides Difficile Infection in Colorectal Cancer Patients
Medical University of Gdansk
Phase NA Unknown
NCT00003057 2023-06-18
Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer
Eastern Cooperative Oncology Group
Phase 3 Completed
NCT05339230 2022-05-25
SALFLADMET
Uppsala University Hospital
Phase NA Unknown
NCT00197873 2021-11-24
Lactobacillus Rhamnosus in Prevention of Chemotherapy-related Diarrhoea
University of Helsinki
Phase NA Completed
NCT04003181 2021-09-08
The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon
University of Aarhus
Phase NA Completed
NCT04874883 2021-05-06
Effect of the Use of Symbiotics in Patients With Colon Cancer
Federal University of Minas Gerais
Phase 4 Unknown
NCT00748215 2020-12-02
Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02182466 2017-12-15
DEKOR
Johann Wolfgang Goethe University Hospital
Terminated
NCT02121626 2017-11-22
FOCCUS
Royal Marsden NHS Foundation Trust
Completed
NCT01523431 2017-03-30
Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Phase 2/3 Completed
NCT00040391 2016-12-01
A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer
Celgene Corporation
Phase 2 Terminated
NCT00033605 2016-07-13
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00048971 2016-07-06
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
Alliance for Clinical Trials in Oncology
Completed
NCT01164215 2015-10-09
Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT00582426 2015-05-04
LARCID
Novartis
Phase 3 Completed
NCT01410955 2014-01-23
Prevention of Irinotecan Induced Diarrhea by Probiotics
Monsea Ltd.
Phase 3 Completed
NCT01863303 2013-05-27
Epidemiological Study of Colorectal Cancer in WuHan
Wuhan Pu-Ai Hospital
Unknown
NCT00084721 2013-01-31
Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer
Roswell Park Cancer Institute
Phase 1 Completed
NCT01438645 2013-01-17
ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy
University of Alberta
Phase NA Completed
NCT00006269 2012-05-25
Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer
Novartis
Phase 3 Terminated
NCT00050635 2009-11-19
STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
Novartis
Phase 4 Completed
NCT00036517 2005-06-24
Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer
PhytoCeutica
Phase 1/2 Terminated